Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Injection of Sirolimus in the Treatment of Aggressive Retinal Astrocytic Hamartoma

NCT04707209 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT04707209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Injection of Sirolimus in the Treatment of Aggressive Retinal Astrocytic Hamartoma
Lead sponsor
The Hospital for Sick Children
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2020
Completion date
March 22, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinal astrocytic hamartoma